WORCESTER, Mass., Sept. 5, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, will present study results at the 44th Annual Meeting of the European Association for the Study of Diabetes (EASD, www.easd.org) to be held in Rome, Italy, September 6 - 11, 2008 (www.easd2008.com).
